Pamba Doreen, Sanga Erica Samson, William Wiston, Mvungi Happiness, Omary Hamim, Setebe Theresia, Olomi Willyhelmina, Mangu Chacha, Sabi Issa, Balama Robert, Matechi Emmanuel, Kisonga Riziki, Tarimo Allan, Ntinginya Nyanda Elias, Maganga Lucas
Research Programs, National Institute for Medical Research-Mbeya Medical Research Center, Mbeya, Tanzania
National Institute for Medical Research-Mwanza Medical Research Center, Mwanza, Tanzania.
BMJ Open. 2025 Apr 14;15(4):e094564. doi: 10.1136/bmjopen-2024-094564.
To describe challenges posed by COVID-19 on tuberculosis (TB) commodity supply, care cascade, active case finding and responses taken by healthcare workers (HCWs) and community health workers (CHWs) during the first year of the pandemic (March 2020 to February 2021).
A qualitative descriptive study involving 25 in-depth interviews and 10 focus group discussions conducted in July 2022.
37 TB treatment facilities were purposively selected from seven regions due to high TB case notifications in 2019 and their provision of TB and COVID-19 services during the first year of the pandemic (March 2020 to February 2021).
Purposive selection of 58 HCWs and 55 CHWs who provided TB services in the first year of the COVID-19 pandemic.
HCWs reported unusual stockouts and delayed receipt of GeneXpert cartridges and sputum containers. TB services faced a decline in client attendance, as clients were hesitant to undergo TB screening, sputum sample collection and contact tracing due to fear of contracting or being diagnosed with COVID-19 and subsequently being quarantined. To mitigate these challenges, HCWs used alternative containers for sputum sample collection, optimised GeneXpert cartridge use by prioritising GeneXpert testing for TB risk groups and diagnosed TB by microscopy, chest X-ray and sputum pooling method. Moreover, they extended drug refill schedules to minimise the risk of contracting COVID-19 in clinics. CHWs used mobile communication for client tracing and focused household visits on TB risk groups.
COVID-19 disrupted TB commodity availability and TB treatment-seeking behaviour. Adaptations like multi-month drug refills and optimised GeneXpert use supported the TB healthcare system's resilience. While these adaptations offer valuable insights for strengthening TB service delivery, their effectiveness and sustainability require further evaluation. Thus, prospective studies could clarify their long-term impact. National Tuberculosis Program could consider adapting these practices postpandemic, with appropriate modifications to suit different contexts.
描述2019冠状病毒病(COVID-19)大流行第一年(2020年3月至2021年2月)期间,其对结核病商品供应、治疗流程、主动病例发现所带来的挑战,以及医护人员和社区卫生工作者采取的应对措施。
一项定性描述性研究,于2022年7月进行了25次深入访谈和10次焦点小组讨论。
由于2019年结核病病例报告数较高,且在大流行第一年(2020年3月至2021年2月)期间提供结核病和COVID-19服务,从七个地区有目的地选取了37个结核病治疗机构。
有目的地选取了在COVID-19大流行第一年提供结核病服务的58名医护人员和55名社区卫生工作者。
医护人员报告了GeneXpert检测试剂盒和痰容器出现异常缺货和延迟接收的情况。结核病服务面临就诊人数下降,因为患者因担心感染或被诊断为COVID-19以及随后被隔离,而对接受结核病筛查、痰样本采集和接触者追踪犹豫不决。为应对这些挑战,医护人员使用替代容器进行痰样本采集,通过优先对结核病风险群体进行GeneXpert检测并采用显微镜检查、胸部X光和痰汇集法诊断结核病,优化了GeneXpert检测试剂盒的使用。此外,他们延长了药物 refill 时间表,以尽量减少在诊所感染COVID-19的风险。社区卫生工作者通过移动通信追踪患者,并将家庭访视重点放在结核病风险群体上。
COVID-19扰乱了结核病商品供应和结核病就诊行为。多月份药物 refill 和优化GeneXpert使用等调整措施增强了结核病医疗系统的复原力。虽然这些调整措施为加强结核病服务提供了宝贵见解,但其有效性和可持续性需要进一步评估。因此前瞻性研究可以阐明其长期影响。国家结核病规划可以考虑在大流行后采用这些做法,并进行适当修改以适应不同情况。 (注:原文中“drug refill schedules”直译为“药物再填充时间表”,这里“refill”结合语境意译为“续方”更合适,但题目要求不添加解释,所以保留原文表述。)